ZYBERNO
Stock Report
Updated Aug 21, 2026

EDAP TMS SA (FOCL)

Healthcare • NASDAQ

$4.17

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
EDAP TMS SA (FOCL) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-110.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

EDAP TMS SA (FOCL) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:4.17
Market Cap:$156.49M

Valuation Multiples (2)

P/S Ratio:2.22x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$176.55M

Price Action & Momentum (3)

Momentum Percentile:97 / 100
% of 52-Week High:65.2%
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:13.2%
Fundamental Growth Rate (g):-14.6%

Margin Analysis (1)

Ebitda Margin:-30.9%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.60x
Quick Ratio:1.38x
Cash Ratio:0.58x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-31.30x
Times Interest Earned:-31.30

Capital Structure (4)

Working Capital:22,166,000.00
Cash And Cash Equivalents:21,542,000.00
Long Term Debt:$37.20M
Net Debt:$20.06M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$70.53M
Cost Of Revenue Ttm:$40.53M

Profitability Breakdown (2)

$30.00M-$24.69M

Bottom Line Performance (3)

-$29.25M
Income Before Tax:-$14.40M
Ebitda Ttm:-21,786,000.00

Operating Expenses (5)

Operating Expenses:15,512,000.00
R And D Expense:2,317,000.00
Sga Expense:5,519,000.00
Income Tax Expense:$8.00K
Interest Expense:789,000.00

Expense Ratios (3)

R And D To Revenue Percentage:17.5%
Sga To Revenue Percentage:41.8%
Ebitda Margin:-30.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$74.55M
Current Assets:$59.02M
Ppe Net:9,882,000.00
Goodwill:735,000.00
Intangible Assets:$1.77M

Liability Structure (4)

Total Liabilities:77,773,000.00
Current Liabilities:36,849,000.00
Long Term Debt:$37.20M
Short Term Debt:$4.41M

Equity & Capital (3)

Equity:-$3.23M
Retained Earnings:-$152.19M
Common Stock:37,797,483.00

Working Capital Items (3)

Accounts Receivable:10,060,000.00
Inventory:8,251,000.00
Accounts Payable:6,426,334.80

Special Items (2)

Contract Liabilities:6,395,000.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$16.41M-$17.36M

Investment Activities (1)

Investing Cash Flow:-$754.00K

Financing Activities (3)

Financing Cash Flow:-$1.37M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$12.42M
Long Term Debt Repayments:$635.00K

Non-Cash Items (1)

Depreciation Amortization Ttm:2,908,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$0.78

Revenue & Cash Per Share (2)

Sales Per Share Ttm:1.88
Operating Cash Flow Per Share:-$0.44

Book Value & Capital (2)

Book Value Per Share:-$0.09
Cash Per Share:0.57

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.96x
Working Capital Turnover Ttm:3.18x

Receivables Management (2)

Receivables Turnover Ttm:7.01x
Days Sales Outstanding Ttm:52.06

Inventory Management (2)

Inventory Turnover Ttm:4.91x
Days Inventory Outstanding Ttm:74.31

Payables & Cash Cycle (2)

Days Payable Outstanding:57.88
Cash Conversion Cycle:68.50
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:25.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:13.2%
Fundamental Growth Rate (g):-14.6%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:FOCL
Company Name:EDAP TMS SA
Sector:Healthcare
Industry:Medical Technology
Exchange:NASDAQ
Country:France

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:37.53M
Shares Outstanding Basic:37.53M
Shares Outstanding Diluted:37.53M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-21 18:44:11 UTC
Data Timestamp:2026-08-19T02:23:05.875542
Scroll to Top